Neoadjuvant/adjuvant relugolix and enzalutamide for the treatment of high-risk locally advanced prostate cancer: study protocol of the RENAPCA phase Ib trial.
Saved in:
| Title: | Neoadjuvant/adjuvant relugolix and enzalutamide for the treatment of high-risk locally advanced prostate cancer: study protocol of the RENAPCA phase Ib trial. |
|---|---|
| Authors: | Loper M; College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA matthewloper18@gmail.com., Qadar A; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Vesely SK; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Gunter T; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Ayanambakkam A; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Wen Y; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Cookson M; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Stratton K; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. |
| Source: | BMJ open [BMJ Open] 2026 Apr 24; Vol. 16 (4), pp. e112623. Date of Electronic Publication: 2026 Apr 24. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42031503 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Neoadjuvant/adjuvant relugolix and enzalutamide for the treatment of high-risk locally advanced prostate cancer: study protocol of the RENAPCA phase Ib trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Loper+M%22">Loper M</searchLink>; College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA matthewloper18@gmail.com.<br /><searchLink fieldCode="AU" term="%22Qadar+A%22">Qadar A</searchLink>; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.<br /><searchLink fieldCode="AU" term="%22Vesely+SK%22">Vesely SK</searchLink>; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.<br /><searchLink fieldCode="AU" term="%22Gunter+T%22">Gunter T</searchLink>; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.<br /><searchLink fieldCode="AU" term="%22Ayanambakkam+A%22">Ayanambakkam A</searchLink>; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.<br /><searchLink fieldCode="AU" term="%22Wen+Y%22">Wen Y</searchLink>; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.<br /><searchLink fieldCode="AU" term="%22Cookson+M%22">Cookson M</searchLink>; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.<br /><searchLink fieldCode="AU" term="%22Stratton+K%22">Stratton K</searchLink>; The Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101552874%22">BMJ open</searchLink> [BMJ Open] 2026 Apr 24; Vol. 16 (4), pp. e112623. <i>Date of Electronic Publication: </i>2026 Apr 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101552874 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-6055 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220446055%22">20446055 </searchLink><i>NLM ISO Abbreviation: </i>BMJ Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42031503 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/bmjopen-2025-112623 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e112623 Titles: – TitleFull: Neoadjuvant/adjuvant relugolix and enzalutamide for the treatment of high-risk locally advanced prostate cancer: study protocol of the RENAPCA phase Ib trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Loper M – PersonEntity: Name: NameFull: Qadar A – PersonEntity: Name: NameFull: Vesely SK – PersonEntity: Name: NameFull: Gunter T – PersonEntity: Name: NameFull: Ayanambakkam A – PersonEntity: Name: NameFull: Wen Y – PersonEntity: Name: NameFull: Cookson M – PersonEntity: Name: NameFull: Stratton K IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 04 Text: 2026 Apr 24 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2044-6055 Numbering: – Type: volume Value: 16 – Type: issue Value: 4 Titles: – TitleFull: BMJ open Type: main |
| ResultId | 1 |
